Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance, with a focus on international growth and a significant backlog. The Q&A section supports this with positive analyst sentiment, especially regarding pricing and contract timelines. Despite some uncertainties in U.S. government spending, the company's strategic plans and liquidity position are robust. The positive outlook for revenue and EBITDA growth, coupled with strong margins and a focus on free cash flow, suggests a positive stock price movement in the short term.
Contract Bookings $240 million in contract bookings, with the majority comprised of international multiyear contracts. This contributed to a growing backlog of $345 million, providing strong revenue visibility.
Q4 Revenue $35 million, representing a 16% year-over-year increase. The growth was driven by new mission solutions contracts, key program milestones, and increased subscription access by international customers.
Annual Revenue $107 million for 2025, with a significant step-up in revenue contribution from international contracts. International revenues grew over 50% from the prior year and now represent more than half of total revenues.
Adjusted EBITDA $8.8 million for Q4 2025, a 20% increase year-over-year. Full-year adjusted EBITDA was $900,000, marking the second consecutive year of positive adjusted EBITDA. The increase was driven by higher revenues and responsible cost management.
Cash Operating Expenses $17.7 million for Q4 2025, compared to $16.9 million in the prior year. Full-year cash operating expenses were $74.3 million, up from $64.9 million in 2024, primarily due to the LeoStella acquisition in 2024.
Liquidity Position $225 million at the end of 2025, an 84% increase over 2024. This was achieved through major contract milestones, reduced unbilled receivables, and a new vendor financing agreement for Gen-3 launches.
Gen-3 satellites: Successfully launched and commissioned 3 Gen-3 satellites in 2025, delivering 35-centimeter imaging performance. These satellites demonstrated rapid deployment capabilities, with one satellite operational within 12 hours of launch and commercial within 3 weeks.
AI-enabled analytics: Enhanced image clarity from Gen-3 satellites advances real-time AI-enabled analytics, driving new customer adoption and long-term subscription contracts.
International contracts: Secured $240 million in contract bookings, with a majority being international multiyear contracts. International revenues grew over 50% year-over-year, now representing more than half of total revenues.
Sovereign mission solutions: Captured major programs with customers in India, Indonesia, and others for Gen-3 related solutions, consolidating these into mission solutions.
Revenue growth: Achieved near-record Q4 revenue of $35 million, a 16% year-over-year increase, and annual revenue of $107 million.
Adjusted EBITDA: Delivered second consecutive year of positive adjusted EBITDA, with $8.8 million in Q4 and $900,000 for the full year.
Liquidity position: Strengthened liquidity to over $225 million, doubling from the previous year.
Market alignment: Aligned business strategy to focus on three growth vectors: space-based intelligence and AI services, sovereign mission solutions, and advanced technology programs.
Advanced technology programs: Progressed on customer-funded R&D initiatives, including optical intersatellite crosslinks, advanced satellites, and real-time AI processing in space.
U.S. Government Budget Challenges: The company faced challenges due to U.S. government budget constraints, which could impact revenue growth and contract opportunities.
Dependence on International Customers: Revenues from international customers grew significantly and now represent more than half of total revenues. This dependence could pose risks related to geopolitical instability, currency fluctuations, or changes in international policies.
High Capital Expenditures: Projected capital expenditures for 2026 are between $50 million and $60 million, primarily for building out the Gen-3 constellation and advancing technologies. This high level of investment could strain financial resources if revenue growth does not meet expectations.
Supply Chain and Launch Dependencies: The company relies on vendor financing agreements for Gen-3 satellite launches. Any disruptions in the supply chain or launch schedules could delay deployments and impact revenue.
Revenue Concentration Risks: A significant portion of revenue comes from a few large contracts, including multiyear agreements with international customers and the U.S. government. This concentration could pose risks if any major customer reduces or cancels their contracts.
Competitive Pressures: The company operates in a competitive market for space-based intelligence and AI services. Failure to maintain technological leadership or respond to competitive pressures could impact market share and profitability.
Economic Uncertainties: Economic conditions, including inflation and currency fluctuations, could impact operational costs and international revenue.
Revenue Projections for 2026: The company expects full-year 2026 revenue to be between $120 million and $145 million, representing a 24% growth over 2025 at the midpoint of this range. This growth is driven by strong backlog visibility, continued Gen-3 satellite deployments, and a growing pipeline of sales opportunities.
Adjusted EBITDA for 2026: Full-year 2026 adjusted EBITDA is projected to be between $6 million and $18 million, reflecting progress towards sustained profitability while maintaining investments in growth initiatives.
Capital Expenditures for 2026: Capital expenditures for 2026 are projected to be between $50 million and $60 million, primarily focused on building out the Gen-3 constellation and advancing next-generation satellite and AI technologies.
Revenue Timing: Revenue performance in the second half of 2026 is expected to be stronger than in the first half, consistent with historical trends.
Gen-3 Satellite Expansion: The company plans to further expand the Gen-3 satellite constellation throughout 2026, with additional satellites already in production and the next satellite at the launch site.
Market Trends and Growth Opportunities: The company anticipates increased spending and demand for space-based intelligence and AI services over the next decade, with growth opportunities in commercial intelligence, sovereign mission solutions, and advanced technology programs.
International Customer Growth: International customers are expected to continue driving revenue growth, with a significant increase in multiyear contracts and adoption of Gen-3 capabilities.
The selected topic was not discussed during the call.
The earnings call summary indicates strong financial performance, with a focus on international growth and a significant backlog. The Q&A section supports this with positive analyst sentiment, especially regarding pricing and contract timelines. Despite some uncertainties in U.S. government spending, the company's strategic plans and liquidity position are robust. The positive outlook for revenue and EBITDA growth, coupled with strong margins and a focus on free cash flow, suggests a positive stock price movement in the short term.
The earnings call reflects a positive sentiment with strong Gen-3 demand, transitioning agreements to larger contracts, and a growing international market. Despite potential U.S. government contract volatility, the company shows resilience with a 50-50 revenue mix shift towards international clients. The Q&A reveals positive analyst sentiment, with optimism about Gen-3's performance and AI capabilities. The company's strategic market expansion and solid backlog position it well for growth, aligning with optimistic guidance. However, some management responses lacked clarity, slightly tempering enthusiasm.
Despite some uncertainties in government budget and satellite details, the earnings call highlights strong backlog growth, successful Gen-3 satellite deployment, and expanding international business. The positive sentiment is reinforced by a $24.4 million task order and the potential for additional awards. The company's strategic investments in AI and new systems, alongside a maintained revenue guidance, suggest optimism. The Q&A section indicates a trend toward longer-term contracts, further supporting a positive outlook. Overall, the sentiment leans towards a positive stock price movement in the coming weeks.
The earnings call presents a mixed picture. Strong revenue growth and backlog expansion are positive, but higher SG&A expenses and adjusted EBITDA loss due to acquisition costs are concerning. The lack of a shareholder return plan and geopolitical risks further complicate the outlook. Q&A insights reveal strong demand and growth potential, but management's unclear responses on backlog recognition timelines and customer mix add uncertainty. Overall, the positives and negatives balance each other out, suggesting a neutral stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.